These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35688268)

  • 1. Gut microbiota mediates methamphetamine-induced hepatic inflammation via the impairment of bile acid homeostasis.
    Zhang KK; Liu JL; Chen LJ; Li JH; Yang JZ; Xu LL; Chen YK; Zhang QY; Li XW; Liu Y; Zhao D; Xie XL; Wang Q
    Food Chem Toxicol; 2022 Aug; 166():113208. PubMed ID: 35688268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obeticholic acid protects against methamphetamine-induced anxiety-like behavior by ameliorating microbiota-mediated intestinal barrier impairment.
    Yang JZ; Zhang KK; He JT; Chen LJ; Ding JF; Liu JL; Li JH; Liu Y; Li XW; Zhao D; Xie XL; Wang Q
    Toxicology; 2023 Mar; 486():153447. PubMed ID: 36720452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escalating dose-multiple binge methamphetamine treatment elicits neurotoxicity, altering gut microbiota and fecal metabolites in mice.
    Chen LJ; Zhi X; Zhang KK; Wang LB; Li JH; Liu JL; Xu LL; Yoshida JS; Xie XL; Wang Q
    Food Chem Toxicol; 2021 Feb; 148():111946. PubMed ID: 33359793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-chain fatty acids mitigate Methamphetamine-induced hepatic injuries in a Sigma-1 receptor-dependent manner.
    Zhang KK; Yang JZ; Cheng CH; Wan JY; Chen YC; Zhou HQ; Zheng DK; Lan ZX; You QH; Wang Q; Sun J
    Ecotoxicol Environ Saf; 2024 Jul; 280():116538. PubMed ID: 38833980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing the
    Wang LB; Chen LJ; Wang Q; Xie XL
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
    Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
    Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
    Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway.
    Fang S; Wang T; Li Y; Xue H; Zou J; Cai J; Shi R; Wu J; Ma Y
    Int J Biol Macromol; 2022 Apr; 205():23-36. PubMed ID: 35176320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation.
    Xiong X; Ren Y; Cui Y; Li R; Wang C; Zhang Y
    Biomed Pharmacother; 2017 Dec; 96():1292-1298. PubMed ID: 29174575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine induces intestinal injury by altering gut microbiota and promoting inflammation in mice.
    Wang LB; Xu LL; Chen LJ; Zhang KK; Zhang QY; Chen YK; Li JH; Liu JL; Wang Q; Xie XL
    Toxicol Appl Pharmacol; 2022 May; 443():116011. PubMed ID: 35390362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis.
    Hu S; Tang B; Lu C; Wang S; Wu L; Lei Y; Tang L; Zhu H; Wang D; Yang S
    Pharmacol Res; 2024 Aug; 206():107275. PubMed ID: 38908615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
    Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
    BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin mitigates aflatoxin B1-induced liver injury via modulation of gut microbiota/intestinal FXR/liver TLR4 signaling axis in mice.
    Liu S; Kang W; Mao X; Ge L; Du H; Li J; Hou L; Liu D; Yin Y; Liu Y; Huang K
    J Pineal Res; 2022 Sep; 73(2):e12812. PubMed ID: 35652241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
    Jung H; Chen J; Hu X; Sun H; Wu SY; Chiang CM; Kemper B; Chen LF; Kemper JK
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silymarin targets the FXR protein through microbial metabolite 7-keto-deoxycholic acid to treat MASLD in obese mice.
    Yi M; Manzoor M; Yang M; Zhang H; Wang L; Zhao L; Xiang L; Qi J
    Phytomedicine; 2024 Oct; 133():155947. PubMed ID: 39178642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying hepatoprotective mechanism and effective components of Yinchenzhufu decoction in chronic cholestatic liver injury using a comprehensive strategy based on metabolomics, molecular biology, pharmacokinetics, and cytology.
    Li Y; Peng X; Wang G; Zan B; Wang Y; Zou J; Tian T; Meng Q; Shi R; Wang T; Wu J; Ma Y
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117060. PubMed ID: 37598769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.